Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Breast Neoplasms 3 Triple Negative Breast Neoplasms 2 Neoplasms 2 Multiple Myeloma 2 Melanoma 2 Glioma 2 Fallopian Tube Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Thyroid Neoplasms 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Peritoneal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Pain 1 Monoclonal Gammopathy of Undetermined Significance 1 Magnetic Resonance Imaging 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Limited Stage Small Cell Lung Cancer 1 Kidney Neoplasms 1 Hypothyroidism 1 Hyperphagia 1 Hepatic Encephalopathy 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1

Interventions

Morphine 16 Oxycodone 14 Fentanyl 10 Methadone 7 nabiximols 5 Lidocaine 5 Acetaminophen 5 resiniferatoxin 4 Hydromorphone 4 Ethanol 4 Acupuncture Therapy 4 Transcutaneous Electric Nerve Stimulation 3 Buprenorphine 3 Transcranial Direct Current Stimulation 2 Tapentadol 2 Surveys and Questionnaires 2 Standard of Care 2 Sodium Bicarbonate 2 Radiosurgery 2 Radiofrequency Ablation 2 Pharmaceutical Services 2 Naloxone 2 Ketamine 2 Electroacupuncture 2 Dronabinol 2 Control Groups 2 Analgesics, Opioid 2 6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2 tanezumab 1 rofecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Cancer Pain × Glucose × Clear all

NCT01384877 2019-07-12

Subcutaneous Lidocaine For Cancer-Related Pain

British Columbia Cancer Agency

Phase 2/3 Completed

33 enrolled 16 charts

Cancer Pain, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡